Exhibitors and Sponsors
Please see below further details about our exhibitors and sponsors.
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Alexion developed and markets Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two debilitating, ultra-rare and life-threatening disorders caused by chronic uncontrolled complement activation. Alexion is evaluating other potential indications for Soliris and is developing four other highly innovative biotechnology product candidates, including asfotase alfa, an investigational targeted enzyme replacement therapy for patients with hypophosphatasia (HPP), an ultra-rare, genetic, life-threatening metabolic disease.
Satellite Organiser, Key Supporter and Exhibitor
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. For more information, visit www.amgen.com
Eli Lilly and Company Limited is one of the world's largest research-based bio-pharmaceutical companies, dedicated to creating and delivering innovative pharmaceutical healthcare solutions that enable people to live longer, healthier and more active lives. Our research and development efforts constantly strive to address the world’s growing unmet medical needs in several different clinical areas.
Eli Lilly has a significant presence in the UK at several locations:
Erl Wood, Surrey: Home to our European HQ and largest R&D facility outside the US.
Speke, Merseyside: A bulk biotech manufacturing plant which makes both human and animal health products.
Basingstoke, Hampshire: The Headquarters for the UK pharmaceutical business
For information about our products or services, please come and talk to us at the Lilly stand, or log on to the Eli Lilly website at www.lilly.com We look forward to meeting you. Jeff Howe, Sales and Marketing Manager, Osteoporosis email:email@example.com
GM is the leading monthly peer-reviewed journal for primary and secondary care physicians with an interest in the 50+ patient and the conditions that impact upon them. It successfully reaches 23,000 named healthcare professionals with each issue across both primary and secondary care
With the majority of issues requested it is important to request your own copy free of charge at the GM booth. In addition six therapy issues under the banner GM2 - are also published every year, each dedicated to an individual therapy area, including Cardiology / Diabetes / Mental Health / Neurology, Oncology and conditions of Gender. Visit the GM website for more information.
MIMS, or the Monthly Index of Medical Specialities, has been providing healthcare professionals with concise and reliable information on prescription medicines since its launch in 1959. Published monthly, MIMS is one of the most up-to-date prescribing guides in the UK. MIMS is independently compiled by our editorial team, who incorporate around 200 changes every month. In addition to summarising information on more than 2000 prescription products, MIMS includes a number of helpful quick-reference prescribing resources, including drug comparison tables and guideline summaries. Complementing the print edition, MIMS is also available as a fully searchable, interactive website and as an app for iPhone, iPad and Android.
National Osteoporosis Society
Organiser and Exhibitor
The National Osteoporosis Society is the only UK-wide charity offering support to people with osteoporosis, their families and carers through a range of information booklets, a national telephone helpline and a network of regional support groups. The National Osteoporosis Society works to raise awareness of osteoporosis and bone health, fundraises for research, works with healthcare professionals across a wide range of disciplines to facilitate greater understanding of the needs of people with osteoporosis and encourages the government and health services to resource and deliver appropriate services to prevent and treat fractures.
Optasia Medical makes software that facilitates the reading of X-rays for the management of musculoskeletal diseases. Our products are used by physicians to identify and monitor patients who will benefit from treatment. With Optasia software, x-rays can be evaluated more rapidly, accurately and reproducibly. Our flagship product, SpineAnalyzer™ facilitates the assessment and documentation of osteoporotic vertebral fracture. Prevalent vertebral fracture is a key component in the calculation of future fracture risk but is largely under-diagnosed and under-reported. SpineAnalyzer provides a rapid workflow for the assessment of deformity that may indicate vertebral fracture, including a convenient report for the referring physician.
Osteocare (Vitabiotics Ltd)
Vitabiotics has manufactured innovative health care products for over 40 years; a British company committed to human health and research. Based in London, Vitabiotics has created a unique portfolio of products at the forefront of scientific developments in key sectors, including nutrition and women’s health.
Osteocare® is Britain’s favourite family of products specially formulated to help maintain bone health in men and women of all ages.. The range includes Osteocare® Original tablets, Osteocare® Joint, Osteocare® Fizz effervescent tablets, Osteocare® Liquid , Osteocare® Chewable tablets and Osteocare® Plus dual pack with soy isoflavones and Omega-3. www.osteocare.com
ProStrakan Group plc is one of Europe’s fastest growing specialty pharmaceutical companies. We are engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major global markets. Our headquarters are based in Galashiels, Scotland. We market a range of specialist products through our commercial operations based in the UK, Europe and the US where, in addition to country-specific products, our principal pan-European products are: Tostran, Rectogesic and Xomolix. We also have a commercial infrastructure in North America in a strategic alliance with NovaQuest, and have just recently launched Sancuso in the US.
Rothband are pleased to attend the NOS Conference as the new UK distributor for the DXL Calscan. Rothband are an established Health imaging supplier with staff who are experienced in the Imaging Market and Bone densitometry in particular. The DXL Calscan is becoming established as the equipment of choice for peripheral Bone densitometry. Please come and visit our stand where we would be pleased to discuss the DXL Calscan and the exciting new prospective fracture study which validates the DXL Calscan as a valuable tool in Osteoporosis Diagnosis. For further information, please visit our website.
Servier Laboratories Ltd
Satellite Organiser, Key Supporter and Exhibitor
Servier Laboratories is the UK subsidiary of The Servier Research Group, the leading independent French research based pharmaceutical company. The key franchises of the Servier Research Group are rheumatology, cardiovascular disease, diabetes, Central Nervous System and oncology. Servier regularly invests more than 25% of its annual turnover into research, discovering and delivering therapeutic innovations to patients through their healthcare professionals. For further information about Servier click here and for information about Protelos click here.
Based in Berkshire, Vertec has grown in 30 years to become one of the biggest distributors of world class medical devices in the UK. Representing a wide range of technologies from DXA and digital x-ray to radiotherapy consumables and tumour location systems, the company has earned the highest reputation for customer focus and support. In DXA exams for osteoporosis, Vertec is the leading supplier of diagnostic systems in the UK, beginning with the Hologic QDR pencil beam system and culminating in the Discovery series which offers peak precision APEX software, FRAX 10 year integrated reporting and advanced whole body composition. For further information visit our website.